Chris Kelly, general counsel for AmSurg Corporation, is a current member of the Board of Directors for ASCAPAC, ASCA’s political action committee. Kelly often travels to Washington to meet with members of Congress about the crucial role of ASCs in the health care system and the challenges that they face.
“Expansion of our industry’s advocacy initiatives at the federal level is vital to the achievement of our legislative goals. ASCAPAC, and the funds it raises annually are essential components of our industry’s strategy to tell the ASC story to decision-makers in D.C.,” Kelly said.
As a member of ASCAPAC, through AmSurg as well as personal contributions, Kelly knows that “the personal access to members of Congress we secure through ASCAPAC gives our industry the unique opportunity to present its strong value proposition of cost savings, efficiency and high-quality patient care. Contributions to ASCAPAC truly make a difference in DC and beyond.”